[HTML][HTML] Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies

X Zhang, B Tang, J Guo - Translational Neurodegeneration, 2023 - Springer
Parkinson's disease (PD) is one of the most prevalent neurodegenerative diseases. The
typical symptomatology of PD includes motor symptoms; however, a range of nonmotor …

[HTML][HTML] A leaky gut dysregulates gene networks in the brain associated with immune activation, oxidative stress, and myelination in a mouse model of colitis

JS Boles, ME Krueger, JE Jernigan, CL Cole… - Brain, Behavior, and …, 2024 - Elsevier
The gut and brain are increasingly linked in human disease, with neuropsychiatric
conditions classically attributed to the brain showing an involvement of the intestine and …

Are LRRK2 mysteries lurking in the gut?

A de Guilhem de Lataillade… - American Journal …, 2023 - journals.physiology.org
Gut-brain axis and inflammation are two hot topics in Parkinson's disease (PD). In this
setting, the leucine-rich repeat kinase 2 (LRRK2) gene, which encodes the eponym protein …

[HTML][HTML] A landscape of gene expression regulation for synovium in arthritis

F Jiang, SY Hu, W Tian, NN Wang, N Yang… - Nature …, 2024 - nature.com
The synovium is an important component of any synovial joint and is the major target tissue
of inflammatory arthritis. However, the multi-omics landscape of synovium required for …

[HTML][HTML] LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2–GSDMD Axis-Mediated Gut Inflammation

Y Wang, JZ Gao, T Sakaguchi, T Maretzky, P Gurung… - Cells, 2024 - mdpi.com
Leucine-rich repeat kinase 2 (LRRK2) is a serine–threonine protein kinase belonging to the
ROCO protein family. Within the kinase domain of LRRK2, a point mutation known as …

The immune system in Parkinson's disease: what we know so far

C Roodveldt, L Bernardino, O Oztop-Cakmak, M Dragic… - Brain, 2024 - academic.oup.com
Parkinson's disease (PD) is characterised neuropathologically by the degeneration of
dopaminergic neurons in the ventral midbrain, the accumulation of α-synuclein (α-syn) …

[HTML][HTML] Casuarina glauca branchlets' extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies

ME Mohamed, AM El-Shafae, E Fikry… - Frontiers in …, 2023 - frontiersin.org
Ulcerative colitis (UC) is an inflammatory bowel disease that is often resistant to current
treatment options, leading to a need for alternative therapies. Herbal products have shown …

LRRK2 G2019S promotes the development of colon cancer via modulating intestinal inflammation

Y Wang, JZ Gao, T Sakaguchi, T Maretzky, P Gurung… - bioRxiv, 2023 - biorxiv.org
Abstract LRRK2 G2019S is the most prevalent variant associated with Parkinson's disease
(PD), found in 1-3% of sporadic and 4-8% of familial PD cases. Intriguingly, emerging …

LRRK2 G2019S and Parkinson's disease: insight from Neuroinflammation

XY Yao, LN Guan, Q Chen, C Ren - Postgraduate Medical …, 2024 - academic.oup.com
The multiple hypothesis holds that the pathogenesis of Parkinson's disease (PD) requires
many factors such as heredity, environment and ageing. Mutations in Leucine-rich repeat …

[HTML][HTML] Locus coeruleus injury modulates ventral midbrain neuroinflammation during DSS-induced colitis

MG Tansey, J Boles, J Holt, C Cole… - Research …, 2024 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is characterized by a decades-long prodrome, consisting of a
collection of non-motor symptoms that emerges prior to the motor manifestation of the …